Dashboard
Manage Tickers

ALNYALNYLAM PHARMACEUTICALS, INC.

Nasdaq alnylam.com


$ 222.88 $ 57.20 (34.52 %)    

Monday, 24-Jun-2024 15:59:57 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 474.01 $ -6.22 (-1.3 %)
DIA $ 394.05 $ 2.64 (0.67 %)
SPY $ 542.74 $ -1.77 (-0.33 %)
TLT $ 94.32 $ 0.38 (0.4 %)
GLD $ 215.63 $ 0.85 (0.4 %)
$ 222.9
$ 225.79
$ 212.00 x 100
$ 0.00 x 0
$ 209.23 - $ 231.62
$ 141.98 - $ 231.64
9,184,563
na
28.12B
$ 0.70
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-02-2024 03-31-2024 10-Q
2 02-15-2024 12-31-2023 10-K
3 11-02-2023 09-30-2023 10-Q
4 08-03-2023 06-30-2023 10-Q
5 05-04-2023 03-31-2023 10-Q
6 02-23-2023 12-31-2022 10-K
7 10-27-2022 09-30-2022 10-Q
8 07-28-2022 06-30-2022 10-Q
9 04-28-2022 03-31-2022 10-Q
10 02-10-2022 12-31-2021 10-K
11 10-28-2021 09-30-2021 10-Q
12 08-03-2021 06-30-2021 10-Q
13 04-29-2021 03-31-2021 10-Q
14 02-11-2021 12-31-2020 10-K
15 11-05-2020 09-30-2020 10-Q
16 08-06-2020 06-30-2020 10-Q
17 05-06-2020 03-31-2020 10-Q
18 02-13-2020 12-31-2019 10-K
19 10-31-2019 09-30-2019 10-Q
20 08-06-2019 06-30-2019 10-Q
21 05-02-2019 03-31-2019 10-Q
22 02-14-2019 12-31-2018 10-K
23 11-07-2018 09-30-2018 10-Q
24 08-02-2018 06-30-2018 10-Q
25 05-04-2018 03-31-2018 10-Q
26 02-15-2018 12-31-2017 10-K
27 11-07-2017 09-30-2017 10-Q
28 08-09-2017 06-30-2017 10-Q
29 05-05-2017 03-31-2017 10-Q
30 02-15-2017 12-31-2016 10-K
31 11-03-2016 09-30-2016 10-Q
32 08-04-2016 06-30-2016 10-Q
33 05-04-2016 03-31-2016 10-Q
34 02-12-2016 12-31-2015 10-K
35 11-09-2015 09-30-2015 10-Q
36 08-07-2015 06-30-2015 10-Q
37 05-08-2015 03-31-2015 10-Q
38 02-13-2015 12-31-2014 10-K
39 11-06-2014 09-30-2014 10-Q
40 08-08-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

nvidia-affirm-holdings-carnival-corp-alnylam-pharmaceuticals-tesla-why-these-5-stocks-are-on-investors-radars-today
Nvidia, Affirm Holdings, Carnival Corp, Al...
06/25/2024 02:18:47

On Monday, major U.S. indices showed mixed performance. The Dow Jones Industrial Average closed up by nearly 0.7% at 39,411.21,

needham-maintains-buy-on-alnylam-pharmaceuticals-raises-price-target-to-275
Needham Maintains Buy on Alnylam Pharmaceu...
06/24/2024 18:33:45

Needham analyst Joseph Stringer maintains Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Buy and raises the price target from ...

semiconductor-nvidia-woes-deepen-nasdaq-100-slips-dow-rallies-bitcoin-sinks-to-60400-whats-driving-markets-monday
Semiconductor, Nvidia Woes Deepen; Nasdaq ...
06/24/2024 17:17:16

Wall Street faces a continuation of last week’s trend during Monday’s morning trading, with semiconductor stocks selling off he...

hc-wainwright--co-reiterates-buy-on-alnylam-pharmaceuticals-maintains-400-price-target
HC Wainwright & Co. Reiterates Buy on Alny...
06/24/2024 17:16:48

HC Wainwright & Co. analyst Patrick Trucchio reiterates Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Buy and maintains $...

bmo-capital-maintains-outperform-on-alnylam-pharmaceuticals-maintains-234-price-target
BMO Capital Maintains Outperform on Alnyla...
06/24/2024 17:15:42

BMO Capital analyst Kostas Biliouris maintains Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Outperform and maintains $234 pr...

alnylams-closely-watched-phase-3-heart-disease-trial-of-vutrisiran-hits-primary-endpoint-shares-surge
Alnylam's Closely Watched Phase 3 Heart Di...
06/24/2024 13:49:11

Alnylam Pharmaceuticals reports positive results from the HELIOS-B Phase 3 study of vutrisiran for ATTR amyloidosis with cardio...

Core News & Articles
Market-Moving News for June 24th
06/24/2024 12:39:04

ALNY: 14% | Alnylam Pharmaceuticals shares are trading higher after the company announced topline results from its HELIOS-B Pha...

rxo-alnylam-pharmaceuticals-and-other-big-stocks-moving-lower-in-mondays-pre-market-session
RXO, Alnylam Pharmaceuticals And Other Big...
06/24/2024 11:54:53

trading-halt-halt-status-updated-at-72501-am-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 7:25:...
06/24/2024 11:25:08

alnylam-announces-topline-results-from-its-helios-b-phase-3-study-of-vutrisiran-study-achieved-statistical-significance-on-primary-and-all-secondary-endpoints
Alnylam Announces Topline Results From Its...
06/24/2024 11:02:46

trading-halt-halted-at-65500-am-et---trading-halt-halt-news-pending
Trading Halt: Halted at 6:55:00 a.m. ET - ...
06/24/2024 10:55:04

canaccord-genuity-maintains-buy-on-alnylam-pharmaceuticals-maintains-283-price-target
Canaccord Genuity Maintains Buy on Alnylam...
06/21/2024 15:27:10

Canaccord Genuity analyst Whitney Ijem maintains Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Buy and maintains $283 price t...

heres-how-much-1000-invested-in-alnylam-pharmaceuticals-5-years-ago-would-be-worth-today
Here's How Much $1000 Invested In Alnylam ...
06/14/2024 17:00:18

100-invested-in-alnylam-pharmaceuticals-15-years-ago-would-be-worth-this-much-today
$100 Invested In Alnylam Pharmaceuticals 1...
06/13/2024 16:00:56

behind-the-scenes-of-alnylam-pharmaceuticalss-latest-options-trends
Behind the Scenes of Alnylam Pharmaceutica...
06/12/2024 16:46:54

alny---analyzing-alnylam-pharmaceuticalss-short-interest
(ALNY) - Analyzing Alnylam Pharmaceuticals...
05/17/2024 19:30:25

10-health-care-stocks-with-whale-alerts-in-todays-session
10 Health Care Stocks With Whale Alerts In...
05/09/2024 17:35:23

hc-wainwright--co-maintains-buy-on-alnylam-pharmaceuticals-raises-price-target-to-400
HC Wainwright & Co. Maintains Buy on Alnyl...
05/07/2024 11:03:55

HC Wainwright & Co. analyst Patrick Trucchio maintains Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Buy and raises the p...

chardan-capital-maintains-buy-on-alnylam-pharmaceuticals-maintains-225-price-target
Chardan Capital Maintains Buy on Alnylam P...
05/03/2024 12:03:47

Chardan Capital analyst Keay Nakae maintains Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Buy and maintains $225 price target.

needham-reiterates-buy-on-alnylam-pharmaceuticals-maintains-200-price-target
Needham Reiterates Buy on Alnylam Pharmace...
05/02/2024 18:41:02

Needham analyst Joseph Stringer reiterates Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Buy and maintains $200 price target.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)